Cardiovascular Alterations in the Parturient Undergoing Cesarean Delivery With Neuraxial Anesthesia

Katherine W Arendt; Jochen D Muehlschlegel; Lawrence C Tsen

Disclosures

Expert Rev of Obstet Gynecol. 2012;7(1):59-75. 

In This Article

Expert Commentary

Over the past 10 years, clinician-scientists have artfully performed a series of clinical studies that have assisted the clinician in preventing neuraxial anesthesia-induced hypotension. Although left uterine displacement has been utilized for decades, the mode of hydration has changed from administration of a fluid bolus prior to initiation of neuraxial anesthesia, to simply co-loading fluid as the neuraxial technique is being performed. Lower doses of intrathecal local anesthesia supplemented with opioid are now being used and phenylephrine has replaced ephedrine as the vasopressor of choice. The phenylephrine infusion regimens are now widely employed clinically, with clinicians experiencing far fewer episodes of post-neuraxial anesthesia-induced hypotension.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....